The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Jazz Pharmaceuticals PLC

Nasdaq: JAZZ
Last

(U.S.) $164.25

Today's change-3.46 -2.06%
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.
 

Jazz Pharmaceuticals PLC

Nasdaq: JAZZ
Last

(U.S.) $164.25

Today's change-3.46 -2.06%
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.

Jazz Pharmaceuticals PLC down (U.S.)$3.46

Jazz Pharmaceuticals PLC closed sharply lower Thursday, dropping (U.S.)$3.46 or 2.06% to (U.S.)$164.25. Shares have lost 3.82% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 2.81% during the last year.

Key company metrics

  • Open(U.S.) $169.04
  • Previous close(U.S.) $167.71
  • High(U.S.) $169.04
  • Low(U.S.) $163.39
  • Bid / Ask-- / --
  • YTD % change+0.32%
  • Volume262,052
  • Average volume (10-day)507,589
  • Average volume (1-month)474,022
  • Average volume (3-month)438,269
  • 52-week range(U.S.) $137.34 to (U.S.) $194.73
  • Beta0.50
  • Trailing P/E61.61×
  • P/E 1 year forward17.36×
  • Forward PEG0.90×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.67
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue334309328307
Total other revenue--------
Total revenue334309328307
Gross profit--281299280
Total cost of revenue22282927
Total operating expense180193198249
Selling / general / administrative10711210494
Research & development28272597
Depreciation / amortization24253231
Interest expense (income), net operating--------
Unusual expense (income)17190
Other operating expenses, total--------
Operating income15311713058
Interest income (expense), net non-operating-16-16-17-15
Gain (loss) on sale of assets--------
Other--------
Income before tax11910311550
Income after tax88718226
Income tax, total31323424
Net income88718226
Total adjustments to net income--------
Net income before extra. items--718226
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items--718226
Inc. avail. to common incl. extra. items88718226
Diluted net income--718226
Dilution adjustment--------
Diluted weighted average shares63637263
Diluted EPS excluding extraordinary itemsvalue per share--1.121.130.41
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share--1.131.290.26